08:00 , Feb 15, 2016 |  BioCentury  |  Emerging Company Profile

Platelet portrait

thromboDx B.V. has found a new repository to mine for disease diagnosis and treatment response: platelets. The company's most advanced programs are for cancer, where the technology could be easier to use and provide a...
07:00 , Aug 7, 2014 |  BC Innovations  |  Tools & Techniques

Getting personal with CTCs

One of oncology's goals is to tailor cancer treatments for individual patients, which requires technologies to predict what drugs will work for a patient and monitor how a tumor changes over time. A team from...
08:00 , Dec 19, 2013 |  BC Innovations  |  Translation in Brief

Translational tidbits

Consorting with academia GlaxoSmithKline plc has set up an immuno-oncology consortium that invites academics from six cancer centers to view its nonpublic early pipeline programs and share ideas for new therapeutic candidates. The Oncology Clinical...
08:00 , Nov 18, 2013 |  BC Week In Review  |  Company News

ApoCell, Fraunhofer Institute for Cell Therapy and Immunology (IZI) deal

ApoCell established its ApoCell Europe GmbH European division, which partnered with not-for-profit Fraunhofer IZI to develop ApoCell's ApoStream . The detection device using dielectrophoresis field flow fractionation to isolate and recover circulating tumor cells (CTCs)....
07:00 , Apr 8, 2013 |  BC Week In Review  |  Clinical News

ApoCell regulatory update

FDA granted Orphan Drug designation for Enlivex's ApoCell to treat graft-versus-host disease (GvHD). An open-label, Israeli Phase I/II trial showed that ApoCell reduced the incidence of GvHD grades 2-4 by half compared to historical controls...
08:00 , Nov 12, 2012 |  BC Week In Review  |  Clinical News

ApoCell: Phase I/II data

An open-label, Israeli Phase I/II trial in 13 patients showed that 4 escalating-doses of ApoCell given before bone marrow transplant led to no safety concerns. ApoCell also reduced the incidence of GvHD grades 2-4 by...
07:00 , Apr 30, 2012 |  BC Week In Review  |  Clinical News

ApoStream diagnostic data

Data from blood samples of patients with HCC showed that ApoCell's ApoStream isolated a greater number of CTCs compared to Veridex LLC's CellSearch Circulating Tumor Cell Kit . Data were presented at the American Association...
07:00 , Oct 5, 2009 |  BC Week In Review  |  Financial News

ApoCell completes venture financing

ApoCell Inc. , Houston, Texas   Business: Diagnostic   Date completed: 9/30/09   Type: Venture financing   Raised: Undisclosed   Investors: Summit Partners  ...